Results 81 to 90 of about 5,549 (198)

Nozokomiyal Pseudomonas Aerugınosa İzolatlarında Doripenem Duyarlılık Oranlarının E-Test Yöntemiyle Araştırılması

open access: yesSakarya Tıp Dergisi, 2011
Amaç: Karbapenemlerin en yeni üyesi olan ve ülkemizde son dönemde kullanıma giren doripenemin nozokomiyal Pseudomonas aeruginosa (P.aeruginosa) izolatlarında in-vitro etkinliğinin araştırılması amaçlanmıştır.Gereç ve Yöntem: Bu amaçla 2008-2010 yılları
Abdullah Bektaş   +4 more
doaj   +1 more source

Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian study

open access: yesBrazilian Journal of Infectious Diseases
In vitro activity of doripenem and comparator antimicrobial agents was evaluated against Gram-negative bacilli recently isolated from Brazilian private hospitals that were enrolled in the INVITA-A-DORI Brazilian Study. A total of 805 unique Gram-negative
Ana Cristina Gales   +4 more
doaj   +1 more source

Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia

open access: yesBrazilian Journal of Infectious Diseases, 2011
Objectives: This study was designed to simulate standard and optimized dosing regimens for intravenous antibiotics against contemporary populations of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa using MIC ...
Maria Virginia Villegas, MD, MSc   +4 more
doaj   +1 more source

Preparation and characterization of formic acid modulated HKUST-1 for doripenem drug delivery [PDF]

open access: yes, 2022
Doripenem is an antibiotic with high effectiveness in treating infections. However, the dose of doripenem is only partially used, so the rest will be wasted through the secretory system.
Denesa, Erwhyanta Monorizho   +1 more
core  

Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii

open access: yes, 2015
Acinetobacter baumannii is the most common species to have developed resistance to antibiotics. Due to increasing levels of drug resistance, the available therapeutic options are insufficient in A. baumannii infections.
Doğanay, Mehmet   +5 more
core   +2 more sources

Pharmacokinetics of doripenem in CSF of patients with non-inflamed meninges

open access: yes, 2012
Objectives: To investigate intact blood-brain barrier (BBB) penetration by doripenem and characterize doripenem pharmacokinetics in CSF using a pharmacokinetic model.
Charkoftaki, G.   +11 more
core  

Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy

open access: yes, 2017
An 11-year-old African American male with severe combined immunodeficiency variant, non-cystic fibrosis bronchiectasis, pancreatic insufficiency, chronic mycobacterium avium-intracellulare infection, chronic sinusitis, and malnutrition presented with a 1-
Wayne S. Moore   +5 more
core   +1 more source

Pharmacodynamic Profiling of Antimicrobials against Gram-negative Respiratory Isolates from Canadian Hospitals

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2011
The objective of this study was to assess the profile of a variety of dosing regimens for common intravenous antibiotics against contemporary Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa isolates collected in ...
Rebecca A. Keel   +3 more
doaj   +1 more source

Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis.

open access: yes, 2016
Click on the Resource Link to access the article (may not be free).BACKGROUND: Doripenem is approved by the Food and Drug Administration for the treatment of patients with complicated intra-abdominal infections and complicated urinary tract infections ...
Morse, Bryan   +13 more
core   +1 more source

Target site Konzentration von Doripenem in subkutanem und muskulärem Gewebe in Intensivpatienten

open access: yes, 2017
Doripenem (Doribax™) ist ein Breitband Carbapenem, das sowohl gegen Gram positive als auch Gram negative Bakterien wirksam ist. Voraussetzung für eine effiziente Wirkung ist das Erreichen einer ausreichenden Konzentration am Infektionsort.
Köfinger, Petra
core  

Home - About - Disclaimer - Privacy